COVID-19 cases are growing in Texas as a summer surge sweeps across the U.S. A new variant includes "razor blade throat" and ...

GSK is taking to the airwaves to get the message out about respiratory syncytial virus (RSV), presenting a TV special about how the pathogen has affected athletes in the upcoming National Senior Games ...

CDC panel, reshaped by RFK Jr., rejects thimerosal flu shots and backs RSV drug amid resignations, expert criticism and ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

It’s not surprising that, of all the recommendations the U.S. CDC’s vaccine advisory board made at its June meeting, the first one Health and Human Services Secretary Robert Kennedy signed off on ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

As the U.S. approaches the midpoint of summer, the CDC is reporting cases of the virus are growing or likely growing in ...

CDC data shows COVID-19 cases rising in over 26 states, with mild new variants and updated vaccine guidance for adults and ...

By Jack Phillips Contributing Writer While activity for COVID-19 remains low in the United States, recent statistics released ...

The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV.

The reconstituted panel has not discussed RSV vaccination again and has already caused concern among doctors by questioning proven science around flu vaccines and childhood immunizations.

The CDC plans to publish clinical considerations that outline the chronic medical conditions and other risk factors for severe RSV disease to be used under this recommendation.